US MD with Finance Background - Interested in Biotech HF/ER

I'm currently in residency with a US MD and a BBA in Finance from a Top 20 with previous internships during undergrad in IB and PE

As the title says, I'm interested in breaking into biotech ER or HF. I have networked with MDs in these roles. I have seen the following pathways to biotech HF:

1) directly out of MD (upon graduation) or during residency

2) SS Biotech ER -> biotech HF

3) Life Sciences Consulting -> biotech HF or Life Sciences Consulting -> SS biotech ER -> biotech HF

4) Industry -> SS biotech ER -> biotech HF

5) biotech VC -> biotech HF

I'm planning on trying to get into biotech HF directly or SS biotech ER -> HF, as opposed to the other pathways I outlined above. 

I'd love to hear from people with an MD, PhD or MD/PhD in ER, VC or HF, and learn about your experience networking into these roles, your experience in these roles and your career progression. 

5 Comments
 

Based on the most helpful WSO content, here are some insights and pathways for an MD with a finance background interested in breaking into biotech HF or ER:

Pathways to Biotech HF/ER:

  1. Directly Out of MD (Upon Graduation) or During Residency:

    • This is a less common but possible route. Networking is crucial here, as direct entry often relies on strong connections and demonstrating relevant skills and interest.
  2. Sell-Side (SS) Biotech ER -> Biotech HF:

    • This is a well-trodden path. Starting in sell-side biotech equity research provides valuable industry exposure and analytical experience, making the transition to hedge funds smoother.
  3. Life Sciences Consulting -> Biotech HF or Life Sciences Consulting -> SS Biotech ER -> Biotech HF:

    • Consulting in life sciences can offer a broad understanding of the industry, which is beneficial for both ER and HF roles. Transitioning from consulting to ER and then to HF is a strategic move.
  4. Industry -> SS Biotech ER -> Biotech HF:

    • Gaining experience in the biotech industry can provide practical insights and expertise. Moving from an industry role to sell-side ER and then to HF leverages this experience effectively.
  5. Biotech VC -> Biotech HF:

    • Venture capital experience in biotech can be highly valuable for hedge funds, especially those focused on early-stage investments. This pathway is less common but offers a unique perspective.

Networking and Career Progression:

  • Networking:

    • Engage with professionals in ER, VC, and HF through informational interviews and industry events.
    • Leverage your existing network from your finance internships and medical school connections.
    • Highlight your unique combination of medical and financial expertise.
  • Experience in Roles:

    • Equity Research (ER): Involves analyzing biotech companies, creating financial models, and providing investment recommendations. It requires strong analytical skills and industry knowledge.
    • Venture Capital (VC): Focuses on identifying and investing in promising biotech startups. It involves due diligence, market analysis, and strategic guidance.
    • Hedge Funds (HF): Involves managing investment portfolios, conducting deep research, and making high-stakes investment decisions. It requires a strong understanding of market dynamics and risk management.
  • Career Progression:

    • Start with roles that build your analytical and industry expertise, such as ER or consulting.
    • Transition to roles with more strategic and investment responsibilities, like VC or HF.
    • Continuously build your network and stay updated on industry trends and developments.

Additional Tips:

  • Leverage Your Background:

    • Emphasize your unique combination of medical and financial knowledge in your resume and during interviews.
    • Highlight any relevant projects or research you have conducted.
  • Stay Informed:

    • Keep up with the latest developments in the biotech industry and financial markets.
    • Consider additional certifications or courses in finance or biotech to strengthen your profile.

By following these pathways and strategies, you can effectively position yourself for a successful career in biotech HF or ER.

Sources: Biotech finance: from IB to VC / HF to funded startup, 3 Key Tips for Getting an ER Interview, MD (Medical Doctor) wanting to get into healthcare ER, Ask Me Anything : Anon1254, 3 Key Tips for Getting an ER Interview

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 
Most Helpful

Good question. While I did not specifically go to medical school with the plan of exiting later to biotech investing roles, I maintained a strong interest in finance as a medical student, which led me to network quite a bit, primarily with MDs at MBB or in biotech VC. Still, I wasn't willing to throw in the towel and was determined to finish my MD regardless of my nonclinical interests. I would say that medical school was extremely difficult for me specifically, as I am strong with quantitative and analytical thinking, but very weak with rote memorization, regurgitating medical factoids, etc. This was actually never a problem before med school despite doing very well in prereqs. The sheer volume of information that was required to be memorized felt absurd at times. I came very close to going to MBB/T2 before graduation instead of residency, but wanted to at least try my hand at practicing as a physician in residency. Residency only clarified my nonclinical interests. 

 

Amet voluptate distinctio qui maxime fugit nostrum. Ducimus nesciunt saepe voluptas quo ullam. Quia atque omnis unde suscipit in quos voluptatem.

Rem neque eveniet est impedit quos odio iure sit. Neque eos tempore ad hic sint et repudiandae. Est ea voluptas expedita unde esse itaque ut. Ducimus hic cupiditate dicta assumenda deleniti iure quo.

Fugit aut et voluptatem ratione voluptates omnis labore. Eos saepe pariatur aut reiciendis esse mollitia. Dignissimos dolore animi accusamus esse non expedita. Architecto est omnis nihil voluptatem distinctio molestiae.

Dolor porro magnam nihil et id ipsa saepe. Reprehenderit consequatur omnis non molestias fugiat corporis voluptatibus. Assumenda ullam aliquid voluptatem blanditiis in nemo. Impedit placeat illo dolores.

Career Advancement Opportunities

September 2026 Hedge Fund

  • Point72 99.0%
  • D.E. Shaw 98.0%
  • Citadel Investment Group 97.0%
  • AQR Capital Management 96.0%
  • Magnetar Capital 95.0%

Overall Employee Satisfaction

September 2026 Hedge Fund

  • Magnetar Capital 99.0%
  • D.E. Shaw 98.0%
  • Blackstone Group 97.0%
  • Citadel Investment Group 96.0%
  • Two Sigma Investments 94.9%

Professional Growth Opportunities

September 2026 Hedge Fund

  • AQR Capital Management 99.0%
  • Point72 98.0%
  • D.E. Shaw 97.1%
  • Citadel Investment Group 96.1%
  • Magnetar Capital 95.1%

Total Avg Compensation

September 2026 Hedge Fund

  • Portfolio Manager (9) $1,648
  • Vice President (27) $464
  • Director/MD (11) $372
  • NA (9) $320
  • Engineer/Quant (83) $287
  • 3rd+ Year Associate (26) $284
  • Manager (4) $282
  • 2nd Year Associate (32) $253
  • 1st Year Associate (76) $193
  • Analysts (234) $178
  • Intern/Summer Associate (29) $145
  • Junior Trader (5) $102
  • Intern/Summer Analyst (276) $95
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Secyh62's picture
Secyh62
99.0
4
kanon's picture
kanon
99.0
5
dosk17's picture
dosk17
98.9
6
GameTheory's picture
GameTheory
98.9
7
Betsy Massar's picture
Betsy Massar
98.9
8
DrApeman's picture
DrApeman
98.9
9
CompBanker's picture
CompBanker
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”